S&P 500   4,365.84 (-1.74%)
DOW   34,396.16 (-1.36%)
QQQ   360.94 (-2.54%)
AAPL   142.73 (-1.82%)
MSFT   285.66 (-2.89%)
FB   340.74 (-3.63%)
GOOGL   2,718.40 (-3.65%)
TSLA   779.55 (-1.49%)
AMZN   3,309.36 (-2.83%)
NVDA   208.34 (-3.81%)
BABA   149.42 (-0.51%)
NIO   35.09 (-4.57%)
CGC   14.22 (-3.33%)
GE   105.01 (-0.32%)
MU   73.43 (-2.33%)
AMD   102.92 (-4.84%)
T   27.27 (-0.47%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   174.03 (-2.37%)
PFE   42.88 (-1.58%)
BA   218.92 (-2.34%)
AMC   37.52 (-4.53%)
S&P 500   4,365.84 (-1.74%)
DOW   34,396.16 (-1.36%)
QQQ   360.94 (-2.54%)
AAPL   142.73 (-1.82%)
MSFT   285.66 (-2.89%)
FB   340.74 (-3.63%)
GOOGL   2,718.40 (-3.65%)
TSLA   779.55 (-1.49%)
AMZN   3,309.36 (-2.83%)
NVDA   208.34 (-3.81%)
BABA   149.42 (-0.51%)
NIO   35.09 (-4.57%)
CGC   14.22 (-3.33%)
GE   105.01 (-0.32%)
MU   73.43 (-2.33%)
AMD   102.92 (-4.84%)
T   27.27 (-0.47%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   174.03 (-2.37%)
PFE   42.88 (-1.58%)
BA   218.92 (-2.34%)
AMC   37.52 (-4.53%)
S&P 500   4,365.84 (-1.74%)
DOW   34,396.16 (-1.36%)
QQQ   360.94 (-2.54%)
AAPL   142.73 (-1.82%)
MSFT   285.66 (-2.89%)
FB   340.74 (-3.63%)
GOOGL   2,718.40 (-3.65%)
TSLA   779.55 (-1.49%)
AMZN   3,309.36 (-2.83%)
NVDA   208.34 (-3.81%)
BABA   149.42 (-0.51%)
NIO   35.09 (-4.57%)
CGC   14.22 (-3.33%)
GE   105.01 (-0.32%)
MU   73.43 (-2.33%)
AMD   102.92 (-4.84%)
T   27.27 (-0.47%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   174.03 (-2.37%)
PFE   42.88 (-1.58%)
BA   218.92 (-2.34%)
AMC   37.52 (-4.53%)
S&P 500   4,365.84 (-1.74%)
DOW   34,396.16 (-1.36%)
QQQ   360.94 (-2.54%)
AAPL   142.73 (-1.82%)
MSFT   285.66 (-2.89%)
FB   340.74 (-3.63%)
GOOGL   2,718.40 (-3.65%)
TSLA   779.55 (-1.49%)
AMZN   3,309.36 (-2.83%)
NVDA   208.34 (-3.81%)
BABA   149.42 (-0.51%)
NIO   35.09 (-4.57%)
CGC   14.22 (-3.33%)
GE   105.01 (-0.32%)
MU   73.43 (-2.33%)
AMD   102.92 (-4.84%)
T   27.27 (-0.47%)
F   14.33 (+1.20%)
ACB   6.78 (+6.10%)
DIS   174.03 (-2.37%)
PFE   42.88 (-1.58%)
BA   218.92 (-2.34%)
AMC   37.52 (-4.53%)
NASDAQ:LBPS

4D pharma Short Interest Ratio and Short Volume

$6.80
+0.05 (+0.74 %)
(As of 09/28/2021 11:38 AM ET)
Add
Compare
Today's Range
$6.74
$6.87
50-Day Range
$6.75
$10.10
52-Week Range
$6.75
$15.50
Volume30 shs
Average Volume22,837 shs
Market Capitalization$111.74 million
P/E RatioN/A
Dividend YieldN/A
Beta0.04

4D pharma (NASDAQ:LBPS) Short Interest Data

Current Short Volume10,400 shares
Previous Short Volume400 shares
Change Vs. Previous Month+2,500.00%
Dollar Volume Sold Short$101,088.00
Short Interest Ratio / Days to Cover0.5
Last Record DateAugust, 31 2021
Outstanding Shares16,433,000 shares
Percentage of Shares Shorted0.06%
Today's Trading Volume30 shares
Average Trading Volume22,837 shares
Today's Volume Vs. Average-99.87%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling 4D pharma ?

Sign up to receive the latest short interest report for 4D pharma and its competitors with MarketBeat's FREE newsletter.

4D pharma (NASDAQ:LBPS) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202110,400 shares $101,088.00 +2,500.0%N/A0.5 $9.72
8/13/2021400 shares $3,611.44 No ChangeN/A0 $9.03

4D pharma (NASDAQ:LBPS) Short Interest FAQ

speech bubbles
speech bubbles











4D pharma (NASDAQ:LBPS) Short Interest Frequently Asked Questions

What is 4D pharma's current short interest?

Short interest is the volume of 4D pharma shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 10,400 shares of LBPS short. Learn More on 4D pharma's current short interest.

Is 4D pharma's short interest increasing or decreasing?

4D pharma saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 10,400 shares, an increase of 2,500.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does 4D pharma's short interest compare to its competitors?

0.00% of 4D pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to 4D pharma: KalVista Pharmaceuticals, Inc. (7.89%), Marinus Pharmaceuticals, Inc. (11.66%), XBiotech Inc. (4.16%), Clene Inc. (4.46%), Akouos, Inc. (10.61%), Applied Therapeutics, Inc. (7.78%), Arbutus Biopharma Co. (4.92%), Kezar Life Sciences, Inc. (4.36%), Magenta Therapeutics, Inc. (3.28%), and Provention Bio, Inc. (6.31%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short 4D pharma stock?

Short selling LBPS is an investing strategy that aims to generate trading profit from 4D pharma as its price is falling. 4D pharma's stock is trading up $0.05 today. To short 4D pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that 4D pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against 4D pharma?

A short squeeze for 4D pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LBPS, which in turn drives the price of the stock up even further.

How often is 4D pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LBPS, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.